S2k guideline on diagnosis and treatment of atopic dermatitis – Short version

Thomas Werfel; Annice Heratizadeh; Werner Aberer; Frank Ahrens; Matthias Augustin; Tilo Biedermann; Thomas Diepgen; Regina Fölster-Holst; Uwe Gieler; Julia Kahle; Alexander Kapp; Alexander Nast; Katja Nemat; Hagen Ott; Bernhard Przybilla; Martin Roecken; Martin Schlaeger; Peter Schmid-Grendelmeier; Jochen Schmitt; Thomas Schwennesen; Doris Staab; Margitta Worm

doi:10.1007/s40629-016-0104-6

S2k guideline on diagnosis and treatment of atopic dermatitis – Short version

Thomas Werfel
, Annice Heratizadeh
, Werner Aberer
, Frank Ahrens
, Matthias Augustin
, Tilo Biedermann
, Thomas Diepgen
, Regina Fölster-Holst
, Uwe Gieler
, Julia Kahle
, Alexander Kapp
, Alexander Nast
, Katja Nemat
, Hagen Ott
, Bernhard Przybilla
, Martin Roecken
, Martin Schlaeger
, Peter Schmid-Grendelmeier
, Jochen Schmitt
, Thomas Schwennesen

Doris Staab, Margitta Worm

Medicine and Health

Medizinische Hochschule Hannover
Medical University of Graz
Altonaer Kinderkrankenhaus
Universitätsklinikum Hamburg-Eppendorf
Universitätsklinikum Heidelberg
University Hospital Schleswig-Holstein
Justus-Liebig-Universität Gießen
Deutscher Allergie- und Asthmabund e.V. (DAAB)
Charité – Universitätsmedizin Berlin
Kinderzentrum Dresden-Friedrichstadt (Kid)
Fachbereich Pädiatrische Dermatologie und Allergologie
Ludwig-Maximilians-Universität München
Universitätsklinikum Tübingen
Praxis für Dermatologie
University Hospital Zurich
Technische Universität Dresden
Deutscher Neurodermitisbund (DNB) e.V.

Research output: Contribution to journal › Review article › peer-review

Abstract

Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral super-infections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www. awmf.org).

Original language	English
Pages (from-to)	82-95
Number of pages	14
Journal	Allergo Journal International
Volume	25
Issue number	3
DOIs	https://doi.org/10.1007/s40629-016-0104-6
State	Published - 2016

Access to Document

10.1007/s40629-016-0104-6

Cite this

Werfel, T., Heratizadeh, A., Aberer, W., Ahrens, F., Augustin, M., Biedermann, T., Diepgen, T., Fölster-Holst, R., Gieler, U., Kahle, J., Kapp, A., Nast, A., Nemat, K., Ott, H., Przybilla, B., Roecken, M., Schlaeger, M., Schmid-Grendelmeier, P., Schmitt, J., ... Worm, M. (2016). S2k guideline on diagnosis and treatment of atopic dermatitis – Short version. Allergo Journal International, 25(3), 82-95. https://doi.org/10.1007/s40629-016-0104-6

@article{5480c68598b347259cf4ff5c001613e6,

title = "S2k guideline on diagnosis and treatment of atopic dermatitis – Short version",

abstract = "Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral super-infections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www. awmf.org).",

author = "Thomas Werfel and Annice Heratizadeh and Werner Aberer and Frank Ahrens and Matthias Augustin and Tilo Biedermann and Thomas Diepgen and Regina F{\"o}lster-Holst and Uwe Gieler and Julia Kahle and Alexander Kapp and Alexander Nast and Katja Nemat and Hagen Ott and Bernhard Przybilla and Martin Roecken and Martin Schlaeger and Peter Schmid-Grendelmeier and Jochen Schmitt and Thomas Schwennesen and Doris Staab and Margitta Worm",

year = "2016",

doi = "10.1007/s40629-016-0104-6",

language = "English",

volume = "25",

pages = "82--95",

journal = "Allergo Journal International",

issn = "2197-0378",

publisher = "Springer Medizin",

number = "3",

}

Werfel, T, Heratizadeh, A, Aberer, W, Ahrens, F, Augustin, M, Biedermann, T, Diepgen, T, Fölster-Holst, R, Gieler, U, Kahle, J, Kapp, A, Nast, A, Nemat, K, Ott, H, Przybilla, B, Roecken, M, Schlaeger, M, Schmid-Grendelmeier, P, Schmitt, J, Schwennesen, T, Staab, D & Worm, M 2016, 'S2k guideline on diagnosis and treatment of atopic dermatitis – Short version', Allergo Journal International, vol. 25, no. 3, pp. 82-95. https://doi.org/10.1007/s40629-016-0104-6

TY - JOUR

T1 - S2k guideline on diagnosis and treatment of atopic dermatitis – Short version

AU - Werfel, Thomas

AU - Heratizadeh, Annice

AU - Aberer, Werner

AU - Ahrens, Frank

AU - Augustin, Matthias

AU - Biedermann, Tilo

AU - Diepgen, Thomas

AU - Fölster-Holst, Regina

AU - Gieler, Uwe

AU - Kahle, Julia

AU - Kapp, Alexander

AU - Nast, Alexander

AU - Nemat, Katja

AU - Ott, Hagen

AU - Przybilla, Bernhard

AU - Roecken, Martin

AU - Schlaeger, Martin

AU - Schmid-Grendelmeier, Peter

AU - Schmitt, Jochen

AU - Schwennesen, Thomas

AU - Staab, Doris

AU - Worm, Margitta

PY - 2016

Y1 - 2016

N2 - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral super-infections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www. awmf.org).

AB - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral super-infections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www. awmf.org).

UR - https://www.scopus.com/pages/publications/85098829508

U2 - 10.1007/s40629-016-0104-6

DO - 10.1007/s40629-016-0104-6

M3 - Review article

AN - SCOPUS:85098829508

SN - 2197-0378

VL - 25

SP - 82

EP - 95

JO - Allergo Journal International

JF - Allergo Journal International

IS - 3

ER -

S2k guideline on diagnosis and treatment of atopic dermatitis – Short version

Abstract

Access to Document

Other files and links

Fingerprint

Cite this